Cooper University Hospital, 1 Cooper Plaza, 3 Dorrance, Camden, NJ 08103, USA.
University of Colorado, Academic Office 1, 12631 East 17th Avenue B130, Aurora, CO 80045, USA.
Heart Fail Clin. 2019 Jan;15(1):109-125. doi: 10.1016/j.hfc.2018.08.011.
Implantable cardioverter-defibrillator and cardiac resynchronization therapy devices have been prescribed for patients with heart failure for several decades. Factors leading to increased usage include significant enhancements in technology and availability of multiple randomized clinical trials demonstrating their benefit with improved implementation of evidence-based guidelines. Despite these advances, gaps still exist in the utilization and referral of these devices, particularly among women. This article reviews the literature on these devices with a focus on gender differences and proposes reasons for why they exist.
几十年来，植入式心脏复律除颤器和心脏再同步治疗设备一直被用于心力衰竭患者。导致使用率增加的因素包括技术的显著进步和多项随机临床试验的出现，这些试验证明了这些设备的益处，并通过更好地实施循证指南来提高其疗效。尽管取得了这些进展，但这些设备的应用和转介方面仍存在差距，尤其是在女性中。本文回顾了这些设备的文献，重点关注性别差异，并提出了存在这些差异的原因。
